Enabling Investments (ACD&P)
Abstract
The Enabling Investments Advanced Component Development and Prototypes (ACD&P) Project maintains the Department of Defense (DoD) advanced development manufacturing facility to rapidly develop, manufacture, and approve medical countermeasures. Enabling efforts in this area support dedicated infrastructure capabilities, demonstrations, and overarching development support functions as portfolio enablers responding to emerging threats. Priority access to the facility provides an on demand manufacturing capability not only for the DoD but for the entire United States Government enterprise. Efforts included in this Project are: (1)Chem Bio Incident Preparedness and Response - Advanced Development and Manufacturing (CBIPR-ADM) The CBIPR-ADM program maintains the DoD-ADM facility in a state of operational readiness so that it can rapidly develop and manufacture medical countermeasures (MCMs) against current and emerging chemical and biological threats including pandemic response. Operational readiness is achieved by establishing and enhancing proven biopharmaceutical manufacturing platform technologies and infrastructure at the facility. By establishing and enhancing proven manufacturing platform technologies and infrastructure, the DoD-ADM facility will have the capability to accelerate development of MCMs at all stages of development, enhance preparedness for existing threats, and rapidly respond to emerging threats as part of a medical integrated layered defense. MCMs impacted by these efforts include: Vaccines for Viral Agents, Vaccines for Bacterial Agents and Toxins, monoclonal antibodies, antibody fragments and conjugates for therapeutic and prophylactic use across all agent classes. Funds to support the facility in a state of operational readiness were previously provided via individual product development and manufacturing funding lines. The Department is now providing dedicated funds. The CBIPR-ADM return on investment is an increased level of preparedness and responsiveness. In FY23, the CBIPR-ADM program continues to establish and enhance new manufacturing platform technologies that will enable the development of MCMs against chemical and biological threats.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2023
- Source ID
- EN4_0603884BP_4_0400_PB_2023
Related Documents
- Root: CHEMICAL/BIOLOGICAL DEFENSE (ACD&P)
- Child Accomplishment: 1) Chem Bio Incident Preparedness and Response - Advanced Development and Manufacturing (CBIPR-ADM)
- Child Cost Item: 7ac54945c24efeb1cb1d227a7b169d9d